$2.22
-0.14-5.93%
At close: Aug 14, 5:00 PM EST
Protalix BioTherapeutics Inc
PLXAMEX
Earnings: Q2 2026 Earnings were released on Wed Aug 12th, before the market open
Conference Call: The most recent conference call started at 8:00 AM, 4 days agoClick to view the webcast
Protalix BioTherapeutics Earnings & Forecasts
Protalix BioTherapeutics (PLX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Protalix BioTherapeutics Guidance
Protalix BioTherapeutics (PLX) last issued guidance on August 12, 2026 for fiscal year 2026. The company guided revenue in the range of $78M - $83M for the period.
Compared to prior guidance, Protalix BioTherapeutics maintained its revenue forecast from a prior range of $78M - $83M.
Protalix BioTherapeutics has issued 3 guidance updates between March 18, 2026 and August 12, 2026. This history provides investors with insight into management's expectations over time.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.01 | $-0.01 | $0.01 | $0.05 |
| Actual | $0.05 | $0.22 | $-0.06 | $0.03 |
| Surprise | +600.0% | +2300.0% | -700.0% | -40.0% |
| Revenue | ||||
| Estimate | $12.9M | $11.5M | $14.4M | $17.9M |
| Actual | $19.9M | $33.8M | $9.3M | $17.7M |
| Surprise | +53.8% | +194.3% | -35.2% | -1.09% |
